GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Joincare Pharmaceutical Group Industry Co Ltd (SHSE:600380) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Joincare Pharmaceutical Group Industry Co (SHSE:600380) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 20, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Joincare Pharmaceutical Group Industry Co EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.


Competitive Comparison of Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.



Joincare Pharmaceutical Group Industry Co  (SHSE:600380) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Joincare Pharmaceutical Group Industry Co EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Joincare Pharmaceutical Group Industry Co's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.


Joincare Pharmaceutical Group Industry Co (SHSE:600380) Business Description

Traded in Other Exchanges
N/A
Address
No. 17 Langshan Road, Joincare Pharmaceutical Group Building, Nanshan New and High-Tech Industrial Development (, Shenzhen, Guangdong, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
Executives
Yu Xiong Directors, senior managers
Zhao Feng Guang senior management
Qiu Qing Feng Directors, senior managers
Tang Ling Zhi senior management
Lin Nan Qi Directors, senior managers
Cao Ping Wei Director
Feng Yan Fang Director
Zhong Shan senior management
Yang Dong Yun senior management
Peng Jin Hua Supervisors
Xie You Guo Supervisors
Guo Xiao Yun Supervisors
Su Qing Wen senior management

Joincare Pharmaceutical Group Industry Co (SHSE:600380) Headlines

No Headlines